← Eichor
Study identifier: NCT06238622 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

Condition: Idiopathic Pulmonary Fibrosis · Progressive Pulmonary Fibrosis  ·  Sponsor: Boehringer Ingelheim

PhasePhase 3
Planned participants1700
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have completed treatment in a previous study with a medicine called nerandomilast or BI 1015550. The goal of this study is to find out how well people with pulmonary fibrosis tolerate long- term treatment with nerandomilast. The study also tests whether nerandomilast improves lung function and prolongs the time until symptoms get worse, participants need to go to the hospital, or die. Every participant takes nerandomilast as tablets for up to 1 year and 10 months. The participants may also continue their regular treatment for pulmonary fibrosis during the study. Participants visit their doctors regularly. During these visits, the doctors collect information on any health problems of the participants. Participants also regularly do lung function tests.

This description comes directly from the study's public registry record.

Talk to the study team

Boehringer Ingelheim  ·  1-800-243-0127  ·  clintriage.rdg@boehringer-ingelheim.com

Always discuss trial participation with your own doctor first.

Locations (373)

University of Alabama at BirminghamBirmingham, Alabama, United StatesNot Yet Recruiting
University of ArizonaTucson, Arizona, United StatesActive Not Recruiting
University of Southern CaliforniaLos Angeles, California, United StatesActive Not Recruiting
Cedars-Sinai Medical CenterLos Angeles, California, United StatesActive Not Recruiting
University of California Los AngelesLos Angeles, California, United StatesActive Not Recruiting
University of California DavisSacramento, California, United StatesRecruiting
National Jewish HealthDenver, Colorado, United StatesActive Not Recruiting
Yale University School of MedicineNew Haven, Connecticut, United StatesActive Not Recruiting
Christiana HospitalNewark, Delaware, United StatesCompleted
Georgetown UniversityWashington D.C., District of Columbia, United StatesActive Not Recruiting
St. Francis Medical InstituteClearwater, Florida, United StatesCompleted
University of FloridaGainesville, Florida, United StatesActive Not Recruiting

+ 361 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06238622